UroGen Pharma Ltd. - URGN
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | Paradigm BioCapital Advisors LP | 3.5% | 1,703,949 | View |
| May 15, 2026 | SCHEDULE 13G/A | Paradigm BioCapital Advisors GP LLC | 3.5% | 1,703,949 | View |
| May 15, 2026 | SCHEDULE 13G/A | Senai Asefaw, M.D. | 3.5% | 1,703,949 | View |
| May 15, 2026 | SCHEDULE 13G/A | Paradigm BioCapital International Fund Ltd. | 3.1% | 1,501,473 | View |
| May 15, 2026 | SCHEDULE 13G | The Toronto-Dominion Bank | 5.4% | 2,616,714 | View |
| May 15, 2026 | SCHEDULE 13G | TD SECURITIES INC. | 0.0% | 1,306 | View |
| Apr 27, 2026 | SCHEDULE 13G | BlackRock, Inc. | 5.2% | 2,519,771 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | The Toronto-Dominion Bank | 4.9% | 2,302,334 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.